Current status: 970 hESC lines, 6090 hiPSC lines, and 143 clinical studies, and 2295 certificates
Monthly statistic from May 1, 2024
Posted on May 1, 2024
| total lines | 7060 |
| hESC lines | 970 |
| hiPSC lines | 6090 |
| derivation countries | 46 |
| projects | 298 |
| providers | 895 |
| clinical studies | 143 |
| subclones | 2728 |
| certificates | 2295 |
| cell line certificates | 2152 |
| project certificates | 143 |